A design alternative for two-stage, phase II, multicenter cancer clinical trialsHERNDON, J. E.Controlled clinical trials. 1998, Vol 19, Num 5, pp 440-450, issn 0197-2456Article

The restricted cubic spline as baseline hazard in the proportional hazards model with step function time-dependent covariablesHERNDON, J. E; HARRELL, F. E.Statistics in medicine. 1995, Vol 14, Num 19, pp 2119-2129, issn 0277-6715Article

Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma?HERNDON, J. E; FLEISHMAN, S; KORNBLITH, A. B et al.Cancer. 1999, Vol 85, Num 2, pp 333-340, issn 0008-543XArticle

Staging non-small cell lung cancer with whole-body PETMAROM, E. M; MCADAMS, H. P; ERASMUS, J. J et al.Radiology. 1999, Vol 212, Num 3, pp 803-809, issn 0033-8419Article

Analysis of neuroendocrine markers, HER2 and CEA before and after chemotherapy in patients with stage IIIA non-small cell lung cancer : A cancer and leukemia group B studyGRAZIANO, S. L; KERN, J. A; HERNDON, J. E et al.Lung cancer. 1998, Vol 21, Num 3, pp 203-211, issn 0169-5002Article

Intrathecal ¹³¹I-labeled antitenascin monoclonal antibody 81C6 treatment of patients with leptomeningeal neoplasms or primary brain tumor resection cavities with subarachnoid communication : Phase I trial resultsBROWN, M. T; COLEMAN, R. E; ZHAO, X. G et al.Clinical cancer research. 1996, Vol 2, Num 6, pp 963-972, issn 1078-0432Article

Localized adenocarcinoma of the lung: oncogene expression of erbB-2 and p53 in 150 patientsHARPOLE, D. H; MARKS, J. R; RICHARDS, W. G et al.Clinical cancer research. 1995, Vol 1, Num 6, pp 659-664, issn 1078-0432Article

Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the cancer and leukemia group BCHAHINIAN, A. P; ANTMAN, K; VOGELZANG, N. J et al.Journal of clinical oncology. 1993, Vol 11, Num 8, pp 1559-1565, issn 0732-183XArticle

Angiographic follow-up after internal mammary artery graft angioplastySKETCH, M. H; QUIGLEY, P. J; PEREZ, J. A et al.The American journal of cardiology. 1992, Vol 70, Num 3, pp 401-403, issn 0002-9149Article

Modulation of O⁶-alkylguanine-DNA alkyltransferase-mediated carmustine resistance using streptozotocin : a phase I trialPANELLA, T. J; SMITH, D. C; SCHOLD, S. C et al.Cancer research (Baltimore). 1992, Vol 52, Num 9, pp 2456-2459, issn 0008-5472Conference Paper

Randomized phase II trial of gemcitabine plus irinotecan or docetaxel in stage IIIB or stage IV NSCLCROCHA LIMA, C. M; RIZVI, N. A; ZHANG, C et al.Annals of oncology. 2004, Vol 15, Num 3, pp 410-418, issn 0923-7534, 9 p.Article

Paclitaxel/ifosfamide or navelbine/ifosfamide chemotherapy for advanced non-small cell lung cancer : CALGB 9532PERRY, M. C; IHDE, D. C; HERNDON, J. E et al.Lung cancer. 2000, Vol 28, Num 1, pp 63-68, issn 0169-5002Article

Correlation of tumor size and survival in patients with stage IA non-small cell lung cancerPATZ, E. F; ROSSI, S; HARPOLE, D. H et al.Chest. 2000, Vol 117, Num 6, pp 1568-1571, issn 0012-3692Article

Dosimetry and dose-response relationships in newly diagnosed patients with malignant gliomas treated with iodine-131-labeled anti-tenascin monoclonal antibody 81C6 therapyAKABANI, G; COKGOR, I; MCLENDON, R. E et al.International journal of radiation oncology, biology, physics. 2000, Vol 46, Num 4, pp 947-958, issn 0360-3016Article

Malignant pleural effusions : Treatment with small-bore-catheter thoracostomy and talc pleurodesisMAROM, E. M; PATZ, E. F; ERASMUS, J. J et al.Radiology. 1999, Vol 210, Num 1, pp 277-281, issn 0033-8419Article

Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients : Clinical implicationsKWIATKOWSKI, D. J; HARPOLE, D. H; GODLESKI, J et al.Journal of clinical oncology. 1998, Vol 16, Num 7, pp 2468-2477, issn 0732-183XArticle

Efficacy of compartmental administration of immunotoxin LMB-1 (B3-LysPE38) in a rat model of carcinomatous meningitisBIGNER, D. D; ARCHER, G. E; MCLENDON, R. E et al.Clinical cancer research. 1995, Vol 1, Num 12, pp 1545-1555, issn 1078-0432Article

Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancerKORNBLITH, A. B; HOLLIS, D. R; NORTON, L et al.Journal of clinical oncology. 1993, Vol 11, Num 11, pp 2081-2089, issn 0732-183XArticle

Edatrexate (10-ethyl-deaza-aminopterin) (NSC #626715) with or without leucovorin rescue for malignant mesothelioma : Sequential phase II trials by the Cancer and Leukemia Group BKINDLER, H. L; BELANI, C. P; HERNDON, J. E et al.Cancer. 1999, Vol 86, Num 10, pp 1985-1991, issn 0008-543XArticle

Dihydro-5-azacytidine and cisplatin in the treatment of malignant mesothelioma : A Phase II study by the Cancer and Leukemia Group BSAMUELS, B. L; HERNDON, J. E; HARMON, D. C et al.Cancer. 1998, Vol 82, Num 8, pp 1578-1584, issn 0008-543XArticle

Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancerCHOI, N. C; HERNDON, J. E; ROSENMAN, J et al.Journal of clinical oncology. 1998, Vol 16, Num 11, pp 3528-3536, issn 0732-183XArticle

A longitudinal study of quality of life in advanced non-small cell lung cancer : Cancer and Leukemia Group B (CALGB) 8931 : Quality of life in comparative cancer clinical trialsHERNDON, J. E; FLEISHMAN, S; KOSTY, M. P et al.Controlled clinical trials. 1997, Vol 18, Num 4, pp 286-300, issn 0197-2456Article

Phase I trial of etoposide, carboplatin, and GM-CSF in extensive small-cell lung cancer : A Cancer and Leukemia Group B study (CALGB 8832)LUIKART, S. D; HERNDON, J. E; GREEN, M. R et al.American journal of clinical oncology. 1997, Vol 20, Num 1, pp 24-30, issn 0277-3732Article

A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expressionHARPOLE, D. H; HERNDON, J. E; WOLFE, W. G et al.Cancer research (Baltimore). 1995, Vol 55, Num 1, pp 51-56, issn 0008-5472Article

Etoposide (VP-16) and cisplatin at maximum tolerated dose in non-small cell lung carcinoma : a Cancer and Leukemia Group B studyMUSCATO, J. J; CIRRINCIONE, C; CLAMON, G et al.Lung cancer. 1995, Vol 13, Num 3, pp 285-294, issn 0169-5002Article